News Image

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: Sep 5, 2024

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease, today announced that Lexeo management will participate in corporate presentations and fireside chats at the following investor conferences:

Read more at globenewswire.com

LEXEO THERAPEUTICS INC

NASDAQ:LXEO (7/25/2025, 8:03:00 PM)

After market: 4.1 -0.03 (-0.73%)

4.13

+0.46 (+12.53%)



Find more stocks in the Stock Screener

Follow ChartMill for more